vs

Side-by-side financial comparison of Align Technology (ALGN) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Align Technology is the larger business by last-quarter revenue ($1.0B vs $1.0B, roughly 1.0× Everus Construction Group, Inc.). Align Technology runs the higher net margin — 13.0% vs 5.5%, a 7.5% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 5.3%). Align Technology produced more free cash flow last quarter ($187.3M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 2.5%).

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandib...

ALGN vs ECG — Head-to-Head

Bigger by revenue
ALGN
ALGN
1.0× larger
ALGN
$1.0B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+27.9% gap
ECG
33.2%
5.3%
ALGN
Higher net margin
ALGN
ALGN
7.5% more per $
ALGN
13.0%
5.5%
ECG
More free cash flow
ALGN
ALGN
$163.8M more FCF
ALGN
$187.3M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
2.5%
ALGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALGN
ALGN
ECG
ECG
Revenue
$1.0B
$1.0B
Net Profit
$135.8M
$55.3M
Gross Margin
65.3%
11.6%
Operating Margin
14.8%
6.8%
Net Margin
13.0%
5.5%
Revenue YoY
5.3%
33.2%
Net Profit YoY
30.8%
60.4%
EPS (diluted)
$1.88
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALGN
ALGN
ECG
ECG
Q4 25
$1.0B
$1.0B
Q3 25
$995.7M
$986.8M
Q2 25
$1.0B
$921.5M
Q1 25
$979.3M
$826.6M
Q4 24
$995.2M
$759.6M
Q3 24
$977.9M
$761.0M
Q2 24
$1.0B
$703.4M
Q1 24
$997.4M
$625.7M
Net Profit
ALGN
ALGN
ECG
ECG
Q4 25
$135.8M
$55.3M
Q3 25
$56.8M
$57.0M
Q2 25
$124.6M
$52.8M
Q1 25
$93.2M
$36.7M
Q4 24
$103.8M
$34.5M
Q3 24
$116.0M
$41.8M
Q2 24
$96.6M
$39.0M
Q1 24
$105.0M
$28.2M
Gross Margin
ALGN
ALGN
ECG
ECG
Q4 25
65.3%
11.6%
Q3 25
64.2%
12.6%
Q2 25
69.9%
13.0%
Q1 25
69.5%
11.2%
Q4 24
70.0%
11.4%
Q3 24
69.7%
11.8%
Q2 24
70.3%
12.6%
Q1 24
70.0%
11.9%
Operating Margin
ALGN
ALGN
ECG
ECG
Q4 25
14.8%
6.8%
Q3 25
9.7%
7.3%
Q2 25
16.1%
7.9%
Q1 25
13.4%
6.2%
Q4 24
14.5%
6.1%
Q3 24
16.6%
7.1%
Q2 24
14.3%
7.3%
Q1 24
15.5%
6.2%
Net Margin
ALGN
ALGN
ECG
ECG
Q4 25
13.0%
5.5%
Q3 25
5.7%
5.8%
Q2 25
12.3%
5.7%
Q1 25
9.5%
4.4%
Q4 24
10.4%
4.5%
Q3 24
11.9%
5.5%
Q2 24
9.4%
5.5%
Q1 24
10.5%
4.5%
EPS (diluted)
ALGN
ALGN
ECG
ECG
Q4 25
$1.88
$1.09
Q3 25
$0.78
$1.11
Q2 25
$1.72
$1.03
Q1 25
$1.27
$0.72
Q4 24
$1.40
$0.68
Q3 24
$1.55
$0.82
Q2 24
$1.28
$0.76
Q1 24
$1.39
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALGN
ALGN
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$4.0B
$629.8M
Total Assets
$6.2B
$1.7B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALGN
ALGN
ECG
ECG
Q4 25
$1.1B
Q3 25
$1.0B
Q2 25
$901.2M
Q1 25
$873.0M
Q4 24
$1.0B
Q3 24
$1.0B
$553.0K
Q2 24
$761.4M
Q1 24
$865.8M
Total Debt
ALGN
ALGN
ECG
ECG
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALGN
ALGN
ECG
ECG
Q4 25
$4.0B
$629.8M
Q3 25
$4.0B
$573.0M
Q2 25
$3.9B
$514.4M
Q1 25
$3.8B
$460.2M
Q4 24
$3.9B
$422.6M
Q3 24
$3.9B
$453.3M
Q2 24
$3.8B
$490.0M
Q1 24
$3.8B
$464.3M
Total Assets
ALGN
ALGN
ECG
ECG
Q4 25
$6.2B
$1.7B
Q3 25
$6.2B
$1.6B
Q2 25
$6.2B
$1.5B
Q1 25
$6.1B
$1.4B
Q4 24
$6.2B
$1.3B
Q3 24
$6.4B
$1.3B
Q2 24
$6.2B
Q1 24
$6.2B
Debt / Equity
ALGN
ALGN
ECG
ECG
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALGN
ALGN
ECG
ECG
Operating Cash FlowLast quarter
$223.2M
$48.2M
Free Cash FlowOCF − Capex
$187.3M
$23.5M
FCF MarginFCF / Revenue
17.9%
2.3%
Capex IntensityCapex / Revenue
3.4%
2.4%
Cash ConversionOCF / Net Profit
1.64×
0.87×
TTM Free Cash FlowTrailing 4 quarters
$490.8M
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALGN
ALGN
ECG
ECG
Q4 25
$223.2M
$48.2M
Q3 25
$188.7M
$76.2M
Q2 25
$128.7M
$25.3M
Q1 25
$52.7M
$7.1M
Q4 24
$286.1M
Q3 24
$263.7M
$78.9M
Q2 24
$159.8M
Q1 24
$28.7M
$21.9M
Free Cash Flow
ALGN
ALGN
ECG
ECG
Q4 25
$187.3M
$23.5M
Q3 25
$169.0M
$65.7M
Q2 25
$107.2M
$12.3M
Q1 25
$27.4M
$-11.4M
Q4 24
$263.1M
Q3 24
$233.9M
$60.9M
Q2 24
$106.4M
Q1 24
$19.3M
$12.6M
FCF Margin
ALGN
ALGN
ECG
ECG
Q4 25
17.9%
2.3%
Q3 25
17.0%
6.7%
Q2 25
10.6%
1.3%
Q1 25
2.8%
-1.4%
Q4 24
26.4%
Q3 24
23.9%
8.0%
Q2 24
10.3%
Q1 24
1.9%
2.0%
Capex Intensity
ALGN
ALGN
ECG
ECG
Q4 25
3.4%
2.4%
Q3 25
2.0%
1.1%
Q2 25
2.1%
1.4%
Q1 25
2.6%
2.2%
Q4 24
2.3%
Q3 24
3.0%
2.4%
Q2 24
5.2%
Q1 24
0.9%
1.5%
Cash Conversion
ALGN
ALGN
ECG
ECG
Q4 25
1.64×
0.87×
Q3 25
3.33×
1.34×
Q2 25
1.03×
0.48×
Q1 25
0.57×
0.19×
Q4 24
2.76×
Q3 24
2.27×
1.89×
Q2 24
1.66×
Q1 24
0.27×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALGN
ALGN

Systems And Services$789.6M75%
Other$258.0M25%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons